Tag: FDA clearance

All

The FDA has accepted Revance's BLA resubmission for DaxibotulinumtoxinA for Injection, designed to treat severe glabellar lines.

Sofwave Medical Ltd reported a 56% revenue increase and $1 million in net income for the third quarter of 2025.